High Cholesterol (Hyperlipidemia) News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Doctor's Tip: What you need to know about cholesterol - Glenwood Springs Post Independent



Glenwood Springs Post Independent
 
Doctor's Tip: What you need to know about cholesterol 
Glenwood Springs Post Independent
Cholesterol is found in arterial plaque, and electron microscope photos show cholesterol crystals poking through the capsule that surrounds plaque, causing plaque rupture, resulting in heart attacks and strokes. There is a genetic abnormality called ...

and more » 


Adenomyosis, Endometriosis Comorbidities Studied - Endometriosis News Today



Endometriosis News Today
 
Adenomyosis, Endometriosis Comorbidities Studied 
Endometriosis News Today
Both gynecological and non-gynecological diseases had significant associations with adenomyosis and endometriosis. Specifically, uterine leiomyoma, a common uterine benign tumor, and benign ovarian tumor were significantly related to both endometriosis ...

 


Including Red Yeast Rice into a Hyperlipidemia Diet - ADVANCE



ADVANCE
 
Including Red Yeast Rice into a Hyperlipidemia Diet 
ADVANCE
Another RCT examined adiponectin, leptin, total cholesterol, high-density lipoprotein (HDL), LDL, and triglycerides in patients with hyperlipidemia who were treated for 8 weeks with red yeast rice.6 Thirty patients identified with primary ...

 


FDA Approves Repatha to Prevent Heart Attack and Stroke - Managed Care magazine



Drug Discovery & Development
 
FDA Approves Repatha to Prevent Heart Attack and Stroke 
Managed Care magazine
Evolocumab (Repatha, Amgen) has become the first PCSK9 inhibitor approved by the FDA to prevent heart attacks, strokes, and coronary revascularizations in adults with established cardiovascular disease. The FDA also approved evolocumab to be used as an ...
FDA OKs Evolocumab for Prevention of Cardiovascular Events Pharmacy Times
FDA approves heart protection label change for Repatha ... PharmaTimes
FDA Approves Amgen's Repatha To Prevent Heart Attack And Stroke Pharmaceutical Processing
Cath Lab Digest (press release)  -Pharmaceutical Business Review 
all 19 news articles » 


FDA Approves Amgen's RepathaŽ (evolocumab) To Prevent Heart ... - Markets Insider



KDAL
 
FDA Approves Amgen's RepathaŽ (evolocumab) To Prevent Heart ... 
Markets Insider
THOUSAND OAKS, Calif., Dec. 1, 2017 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that following priority review of its supplemental Biologics License Application, the U.S. Food and Drug Administration (FDA) approved RepathaŽ (evolocumab) as the ...
Cholesterol-Fighter Repatha Gains PCSK9 Edge With CV Label Change AJMC.com Managed Markets Network
FDA approves evolocumab for prevention of MI, stroke, coronary revascularization Healio

all 9 news articles » 


New Indication Granted for Repatha for Wider Group of Patients: Adults with CVD - Pharmacy Practice News



Pharmacy Practice News
 
New Indication Granted for Repatha for Wider Group of Patients: Adults with CVD 
Pharmacy Practice News
The FDA granted a new indication for evolocumab (Repatha, Amgen) as the first PCSK9 inhibitor to prevent heart attacks, strokes and coronary revascularizations in adults with established cardiovascular disease (CVD). The FDA also approved evolocumab to ...

 


Cholesterol Lowering Drugs Market Industrial Forecast On Global ... - Find Market Research By Abhishek Budholiya (press release) (blog)



Find Market Research By Abhishek Budholiya (press release) (blog)
 
Cholesterol Lowering Drugs Market Industrial Forecast On Global ... 
Find Market Research By Abhishek Budholiya (press release) (blog)
Cholesterol, a waxy, fat-like substance, is essential for the preparation of hormones, vitamin D, and substances that help in the digestion of food. High-density lipoproteins (HDL) and low-density lipoproteins (LDL) carry cholesterol throughout the ...

and more » 


FDA clears Amgen's Repatha for heart protection - BioPharma Dive



FDA clears Amgen's Repatha for heart protection 
BioPharma Dive
The Food and Drug Administration handed Amgen Inc. an early December bonus, granting approval of the biotech's cholesterol drug Repatha for prevention of heart attacks, strokes and coronary revascularizations in adults with established cardiovascular ...

 


Telepharmacy intervention yields modest effect on medication - Healio - Healio



Telepharmacy intervention yields modest effect on medication - Healio 
Healio
ANAHEIM, Calif. ? Implementation of a personalized telepharmacy intervention improved medication adherence but did not affect measures of disease control including LDL cholesterol, BP and HbA1c among patients with chronic cardiometabolic diseases ...

and more » 


AHA: Intervention Has Mixed Results for Adherence to Meds - MedPage Today



AHA: Intervention Has Mixed Results for Adherence to Meds 
MedPage Today
"We wanted to try a novel program, in which the pharmacist was embedded in the healthcare team, that would use technology to ... see if we could help patients with heart disease, with hypertension, with high cholesterol, and diabetes improve their ...